tiprankstipranks
Trending News
More News >
Kuros Biosciences Ltd. (CSBTF)
OTHER OTC:CSBTF
US Market

Kuros Biosciences (CSBTF) Ratios

Compare
14 Followers

Kuros Biosciences Ratios

CSBTF's free cash flow for Q4 2024 was CHF0.88. For the 2024 fiscal year, CSBTF's free cash flow was decreased by CHF and operating cash flow was CHF-0.08. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.14 2.06 2.49 2.91 8.76
Quick Ratio
1.69 1.69 2.24 2.76 8.39
Cash Ratio
0.84 1.08 1.91 2.54 7.32
Solvency Ratio
-0.04 -0.74 -0.83 -0.32 -0.91
Operating Cash Flow Ratio
0.15 -0.67 -0.58 -0.48 -2.38
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
CHF 18.96MCHF 12.44MCHF 17.31MCHF 18.53MCHF 24.20M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.03 0.02 0.02 0.02
Debt-to-Equity Ratio
0.03 0.04 0.03 0.03 0.03
Debt-to-Capital Ratio
0.03 0.04 0.03 0.03 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.44 1.26 1.20 1.19 1.12
Debt Service Coverage Ratio
-6.25 -38.81 -1.72 -2.37 -9.44
Interest Coverage Ratio
-33.52 -70.92 -3.11 -6.34 -13.77
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
0.05 0.06 0.18 0.11 0.13
Net Debt to EBITDA
27.93 1.76 2.51 5.00 3.04
Profitability Margins
Gross Profit Margin
82.10%71.31%59.87%72.86%41.37%
EBIT Margin
-4.23%-39.21%-88.10%-59.15%-278.44%
EBITDA Margin
-0.74%-20.37%-49.15%-38.30%-212.35%
Operating Profit Margin
-6.61%-39.30%-74.76%-63.46%-289.16%
Pretax Profit Margin
-4.43%-39.77%-88.91%-69.16%-299.43%
Net Profit Margin
-4.92%-40.90%-81.15%-54.59%-285.22%
Continuous Operations Profit Margin
-4.92%-40.90%-81.15%-54.59%-285.22%
Net Income Per EBT
111.06%102.85%91.27%78.93%95.25%
EBT Per EBIT
66.99%101.17%118.93%108.98%103.55%
Return on Assets (ROA)
-4.40%-19.21%-17.60%-8.26%-12.21%
Return on Equity (ROE)
-6.33%-24.20%-21.20%-9.80%-13.62%
Return on Capital Employed (ROCE)
-7.85%-22.64%-19.11%-10.95%-12.91%
Return on Invested Capital (ROIC)
-8.65%-23.05%-17.34%-8.61%-12.26%
Return on Tangible Assets
-7.42%-45.03%-42.65%-21.34%-31.26%
Earnings Yield
-0.47%-10.75%-29.29%-11.95%-23.45%
Efficiency Ratios
Receivables Turnover
5.06 4.41 4.97 8.17 3.90
Payables Turnover
1.96 7.40 5.54 4.43 2.53
Inventory Turnover
1.43 1.98 2.28 2.13 1.62
Fixed Asset Turnover
24.99 12.70 7.74 5.65 1.56
Asset Turnover
0.89 0.47 0.22 0.15 0.04
Working Capital Turnover Ratio
3.99 2.05 0.89 0.53 0.16
Cash Conversion Cycle
140.44 217.60 167.90 133.37 174.39
Days of Sales Outstanding
72.14 82.83 73.42 44.68 93.62
Days of Inventory Outstanding
254.86 184.09 160.32 171.06 225.04
Days of Payables Outstanding
186.55 49.32 65.85 82.37 144.27
Operating Cycle
326.99 266.93 233.74 215.74 318.66
Cash Flow Ratios
Operating Cash Flow Per Share
0.08 -0.24 -0.22 -0.17 -0.38
Free Cash Flow Per Share
0.05 -0.25 -0.23 -0.18 -0.39
CapEx Per Share
0.03 <0.01 0.01 0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.65 1.04 1.05 1.07 1.02
Dividend Paid and CapEx Coverage Ratio
2.82 -27.13 -18.37 -14.58 -42.00
Capital Expenditure Coverage Ratio
2.82 -27.13 -18.37 -14.58 -42.00
Operating Cash Flow Coverage Ratio
1.75 -4.13 -3.84 -2.54 -3.95
Operating Cash Flow to Sales Ratio
0.04 -0.26 -0.41 -0.39 -2.29
Free Cash Flow Yield
0.26%-7.18%-15.55%-9.23%-19.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-213.72 -9.30 -3.41 -8.37 -4.26
Price-to-Sales (P/S) Ratio
10.51 3.80 2.77 4.57 12.16
Price-to-Book (P/B) Ratio
13.52 2.25 0.72 0.82 0.58
Price-to-Free Cash Flow (P/FCF) Ratio
391.61 -13.92 -6.43 -10.83 -5.19
Price-to-Operating Cash Flow Ratio
252.93 -14.44 -6.78 -11.58 -5.32
Price-to-Earnings Growth (PEG) Ratio
2.90 0.80 -0.04 0.16 0.15
Price-to-Fair Value
13.52 2.25 0.72 0.82 0.58
Enterprise Value Multiple
-1.39K -16.91 -3.13 -6.93 -2.69
Enterprise Value
EV to EBITDA
-1.39K -16.91 -3.13 -6.93 -2.69
EV to Sales
10.30 3.44 1.54 2.65 5.71
EV to Free Cash Flow
383.89 -12.61 -3.57 -6.29 -2.44
EV to Operating Cash Flow
247.94 -13.07 -3.77 -6.72 -2.50
Tangible Book Value Per Share
0.65 0.43 0.59 0.64 1.11
Shareholders’ Equity Per Share
1.58 1.55 2.03 2.35 3.48
Tax and Other Ratios
Effective Tax Rate
-0.11 -0.03 0.09 0.21 0.05
Revenue Per Share
2.03 0.92 0.53 0.42 0.17
Net Income Per Share
-0.10 -0.38 -0.43 -0.23 -0.47
Tax Burden
1.11 1.03 0.91 0.79 0.95
Interest Burden
1.05 1.01 1.01 1.17 1.08
Research & Development to Revenue
0.09 0.17 0.29 0.36 0.99
SG&A to Revenue
0.07 0.11 0.17 0.19 0.78
Stock-Based Compensation to Revenue
0.07 0.03 0.06 0.03 0.19
Income Quality
-0.80 0.64 0.46 0.57 0.76
Currency in CHF
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis